N/A
N=150
The Effectiveness of Cancer Pain Management in Siriraj Outpatient Pain Clinic
Pain, Chronic · Cancer
Bottom Line
View on ClinicalTrials.gov: NCT03474406 ↗Enrolled (actual)
150
Serious AEs
0.0%
Results posted
Mar 2021
Primary outcome: Primary: Improvement of Pain. — 3 score on a scale (0-10)
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- follow up system and multimodality approach (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mahidol University
- Primary completion
- Mar 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Improvement of Pain. |
3 | — |
| SECONDARY Total Brief Pain Inventory (BPI) |
26 | — |
| SECONDARY Edmonton Symptom Assessment System(ESAS) |
23.5 | — |
| SECONDARY Percentage of Moderate to Severe Sedation |
6 | — |
| SECONDARY Percentage of Moderate to Severe Neausea and Vomitting |
9 | — |
| SECONDARY Percentage of Moderate to Severe Constipation |
17 | — |
| SECONDARY Percentage of Satisfied With the Service (Score=3) |
64 | — |
Summary
-Background: Cancer is one of the most common cause of death. Cancer pain is often cited as one of the most feared in cancer patients. Although, WHO guidelines have been provided to improve pain outcome, the results are still unsatisfied. In order to improve cancer pain management we consider to contribute a new guideline which includes interdisciplinary approach, early doing the pain interventions, breakthrough pain, education, high quality of pain assessment and contribute the effectiveness follow-up system
Eligibility Criteria
Inclusion Criteria
- Cancer pain patients
- more than 18 years old
Exclusion Criteria
- Clinical instability
- Cannot read and write
- Do not know the diagnosis
Data sourced from ClinicalTrials.gov (NCT03474406). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.